Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novartis scientists identify new steryl-sulfatase inhibitors

Nov. 6, 2003

New KDR/Tie-2 kinase inhibitors in early development at Abbott

Nov. 6, 2003

Merck subsidiary seeks approval for Erbitux in Australia

Nov. 5, 2003

Merck presents new KSP inhibitors with utility in cancer therapy

Nov. 5, 2003

Potent Tie-2 inhibitors discovered to be effective in models of angiogenesis

Nov. 4, 2003

Clinical trial evaluates CC-8490 for brain cancer

Nov. 4, 2003

Tissue-selective ERalpha antagonists prepared and tested at Schering AG

Nov. 4, 2003

Collaboration to test MVA-BN with HER-2 DNA AutoVac vaccine

Nov. 4, 2003

Phase III results for G17DT in pancreatic cancer

Nov. 4, 2003

Antitumor fredericamycin analogues developed at Biofrontera

Nov. 3, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...